FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, namely to extraction of exosomes from blood plasma. Method involves using SMP/AptCD63 complexes containing supermagnetic particles (SMP) with diameter of 1 mcm, coated with streptavidin and DNA aptamers AptCD63, modified with biotin molecule. Complexes are formed by incubation of 1 mcg of SMP coated with streptavidin, and 5 nanomoles AptCD63 modified with biotin molecule at room temperature for 30 minutes. Further, the SMP/AptCD63 complexes are washed from the unbound molecules of the aptamer with a phosphate-salt buffer, added to blood plasma with volume of 10-100 mcl and incubated for 10–12 hours at a temperature of +4 °C to form complex SMP/AptCD63/exosome.
EFFECT: invention enables performing exosomal blood plasma isolation for subsequent analysis of surface exosomatic proteins by flow cytometry.
1 cl, 3 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ISOLATION AND ANALYSIS OF EXOSOMES | 2022 |
|
RU2788198C1 |
| METHOD FOR DIAGNOSING COLORECTAL CANCER | 2021 |
|
RU2772203C1 |
| EXOSOME RECOVERY KIT | 2023 |
|
RU2824663C1 |
| METHOD OF DETERMINING THE RISK OF MALIGNANT TRANSFORMATION OF PROSTATE CELLS | 2022 |
|
RU2806518C1 |
| BIOLOGICAL MICROCHIP FOR DETECTION OF TUMOR EXOSOMES IN SERUM OF HUMAN FOR DIAGNOSING COLORECTAL CANCER | 2016 |
|
RU2682721C2 |
| NANO- AND MICROPARTICLES FOR ISOLATING SPECIFIC SUBPOPULATIONS OF EXOSOMES AND ANALYSIS THEREOF | 2020 |
|
RU2733884C1 |
| METHOD OF DETERMINING COMPOSITION OF INDIVIDUAL EXTRACELLULAR VESICLES IN HUMAN BLOOD | 2014 |
|
RU2583940C1 |
| METHOD FOR PLASMA EXOSOME RELEASE | 2020 |
|
RU2741776C1 |
| EXOSOMES AND THEIR USE AS VACCINE | 2016 |
|
RU2763524C2 |
| NOVEL METHOD FOR MEASURING AND DESCRIBING MICROVESICLES IN HUMAN FLUIDS | 2009 |
|
RU2520741C2 |
